Brett M. Behers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brett M. Behers has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin J. Behers
Florida State University Internal Medicine Residency at Sarasota Memorial Hospital, Sarasota, FL 34239, USA
4 shared publications - Anthony Thompson
Florida State University College of Medicine Tallahassee Florida USA
2 shared publications Benjamin J. Behers
Florida State University Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, FL
2 shared publications- Caroline N. Do Wojtas
Florida State University Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, FL
2 shared publications - Julian Melchor
Florida State University
2 shared publications - Manuel A. Rosario
Florida State University Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, FL
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 11 April 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (15) , e42135
Assessing the quality and readability of patient education materials on chemotherapy cardiotoxicity from artificial intelligence chatbots: An observational cross-sectional study
Artificial intelligence (AI) and the introduction of Large Language Model (LLM) chatbots have become a common source of patient inquiry in healthcare. The quality and readability of AI-generated patient education materials (PEM) is the subject of many studies across multiple medical topics. Most demonstrate poor readability and acceptable quality. However, an area yet to be investigated is chemotherapy-induced cardiotoxicity. This study seeks to assess the quality and readability of chatbot created PEM relative to chemotherapy-induced cardiotoxicity. We conducted an observational cross-sectional study in August 2024 by asking 10 questions to 4 chatbots: ChatGPT, Microsoft Copilot (Copilot), Google Gemini (Gemini), and Meta AI (Meta). The generated material was assessed for readability using 7 tools: Flesch Reading Ease Score (FRES), Flesch-Kincaid Grade Level (FKGL), Gunning Fog Index (GFI), Coleman-Liau Index (CLI), Simple Measure of Gobbledygook (SMOG) Index, Automated Readability Index (ARI), and FORCAST Grade Level. Quality was assessed using modified versions of 2 validated tools: the Patient Education Materials Assessment Tool (PEMAT), which outputs a 0% to 100% score, and DISCERN, a 1 (unsatisfactory) to 5 (highly satisfactory) scoring system. Descriptive statistics were used to evaluate performance and compare chatbots amongst each other. Mean reading grade level (RGL) across all chatbots was 13.7. Calculated RGLs for ChatGPT, Copilot, Gemini and Meta were 14.2, 14.0, 12.5, 14.2, respectively. Mean DISCERN scores across the chatbots was 4.2. DISCERN scores for ChatGPT, Copilot, Gemini, and Meta were 4.2, 4.3, 4.2, and 3.9, respectively. Median PEMAT scores for understandability and actionability were 91.7% and 75%, respectively. Understandability and actionability scores for ChatGPT, Copilot, Gemini, and Meta were 100% and 75%, 91.7% and 75%, 90.9% and 75%, and 91.7% and 50%, respectively. AI chatbots produce high quality PEM with poor readability. We do not discourage using chatbots to create PEM but recommend cautioning patients about their readability concerns. AI chatbots are not an alternative to a healthcare provider. Furthermore, there is no consensus on which chatbots create the highest quality PEM. Future studies are needed to assess the effectiveness of AI chatbots in providing PEM to patients and how the capabilities of AI chatbots are changing over time.
- 11 April 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (15) , e42135
Top Cited PapersOpen AccessAssessing the quality and readability of patient education materials on chemotherapy cardiotoxicity from artificial intelligence chatbots: An observational cross-sectional study
Artificial intelligence (AI) and the introduction of Large Language Model (LLM) chatbots have become a common source of patient inquiry in healthcare. The quality and readability of AI-generated patient education materials (PEM) is the subject of many studies across multiple medical topics. Most demonstrate poor readability and acceptable quality. However, an area yet to be investigated is chemotherapy-induced cardiotoxicity. This study seeks to assess the quality and readability of chatbot created PEM relative to chemotherapy-induced cardiotoxicity. We conducted an observational cross-sectional study in August 2024 by asking 10 questions to 4 chatbots: ChatGPT, Microsoft Copilot (Copilot), Google Gemini (Gemini), and Meta AI (Meta). The generated material was assessed for readability using 7 tools: Flesch Reading Ease Score (FRES), Flesch-Kincaid Grade Level (FKGL), Gunning Fog Index (GFI), Coleman-Liau Index (CLI), Simple Measure of Gobbledygook (SMOG) Index, Automated Readability Index (ARI), and FORCAST Grade Level. Quality was assessed using modified versions of 2 validated tools: the Patient Education Materials Assessment Tool (PEMAT), which outputs a 0% to 100% score, and DISCERN, a 1 (unsatisfactory) to 5 (highly satisfactory) scoring system. Descriptive statistics were used to evaluate performance and compare chatbots amongst each other. Mean reading grade level (RGL) across all chatbots was 13.7. Calculated RGLs for ChatGPT, Copilot, Gemini and Meta were 14.2, 14.0, 12.5, 14.2, respectively. Mean DISCERN scores across the chatbots was 4.2. DISCERN scores for ChatGPT, Copilot, Gemini, and Meta were 4.2, 4.3, 4.2, and 3.9, respectively. Median PEMAT scores for understandability and actionability were 91.7% and 75%, respectively. Understandability and actionability scores for ChatGPT, Copilot, Gemini, and Meta were 100% and 75%, 91.7% and 75%, 90.9% and 75%, and 91.7% and 50%, respectively. AI chatbots produce high quality PEM with poor readability. We do not discourage using chatbots to create PEM but recommend cautioning patients about their readability concerns. AI chatbots are not an alternative to a healthcare provider. Furthermore, there is no consensus on which chatbots create the highest quality PEM. Future studies are needed to assess the effectiveness of AI chatbots in providing PEM to patients and how the capabilities of AI chatbots are changing over time.
- Open Access
- 1 April 2025
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 10, 34
Splenic injuries following upper endoscopic procedures: a systematic review of cases
Background: Splenic injury is a rare complication of upper endoscopic procedures described in case reports. These injuries can result in significant morbidity due to the spleen’s vascularity and propensity for intraperitoneal bleeds. This review aims to collect data regarding patient characteristics, procedural factors, clinical presentations and treatment courses for analysis. Methods: A systematic review of case reports on PubMed, Embase, and Web of Science was conducted for splenic injuries following upper endoscopic procedures (as of 14 July 2023). A total of 52 cases from 50 reports were included. All cases were from case reports or series, including conference abstracts, published in English. Cases were excluded if they were: not published in English; dealt with splenic injuries not following upper endoscopic procedures, including colonoscopy; documented a later complication of an upper endoscopic procedure, such as a migrating stent; not case reports or case series, such as review articles. Risk of bias was analyzed with Joanna Briggs Institute critical appraisal tools. Cases were analyzed using descriptive statistics. Results: The mean age was 56 years, with a median of 55 years, and a range of 21–86 years. Prior abdominal surgeries were identified in 31% of cases (16/52), and chronic pancreatitis in 15% (9/52). Procedural difficulty was reported in 21% (11/52). Most occurred following endoscopic retrograde cholangiopancreatography (ERCP) (71%, 37/52). Common symptoms were abdominal pain (79%, 41/52), hypotension and/or tachycardia (67%, 35/52), and postoperative drops in hemoglobin (58%, 30/52). Mean time to symptom onset was 21 hours, with a median of 4 hours, and a range of 0–144 hours. Most were diagnosed with computerized tomography (69%, 36/52), followed by laparotomy (17%, 9/52). Most were treated surgically (76%, 40/52). Most patients recovered fully (82%, 42/51). Conclusions: Splenic injury is a rare complication of upper endoscopy that should be considered given the risk for delayed diagnosis and mortality. Most patients presented with abdominal pain and signs of hemorrhagic shock, although many had delayed onset of symptoms. Potential risk factors include prior abdominal surgeries, chronic pancreatitis, and difficult or prolonged procedures. Our review was limited by a low number of cases and inconsistent reporting of variables, which limited our statistical analysis.
- 1 April 2025
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 10, 34
Open AccessSplenic injuries following upper endoscopic procedures: a systematic review of cases
Background: Splenic injury is a rare complication of upper endoscopic procedures described in case reports. These injuries can result in significant morbidity due to the spleen’s vascularity and propensity for intraperitoneal bleeds. This review aims to collect data regarding patient characteristics, procedural factors, clinical presentations and treatment courses for analysis. Methods: A systematic review of case reports on PubMed, Embase, and Web of Science was conducted for splenic injuries following upper endoscopic procedures (as of 14 July 2023). A total of 52 cases from 50 reports were included. All cases were from case reports or series, including conference abstracts, published in English. Cases were excluded if they were: not published in English; dealt with splenic injuries not following upper endoscopic procedures, including colonoscopy; documented a later complication of an upper endoscopic procedure, such as a migrating stent; not case reports or case series, such as review articles. Risk of bias was analyzed with Joanna Briggs Institute critical appraisal tools. Cases were analyzed using descriptive statistics. Results: The mean age was 56 years, with a median of 55 years, and a range of 21–86 years. Prior abdominal surgeries were identified in 31% of cases (16/52), and chronic pancreatitis in 15% (9/52). Procedural difficulty was reported in 21% (11/52). Most occurred following endoscopic retrograde cholangiopancreatography (ERCP) (71%, 37/52). Common symptoms were abdominal pain (79%, 41/52), hypotension and/or tachycardia (67%, 35/52), and postoperative drops in hemoglobin (58%, 30/52). Mean time to symptom onset was 21 hours, with a median of 4 hours, and a range of 0–144 hours. Most were diagnosed with computerized tomography (69%, 36/52), followed by laparotomy (17%, 9/52). Most were treated surgically (76%, 40/52). Most patients recovered fully (82%, 42/51). Conclusions: Splenic injury is a rare complication of upper endoscopy that should be considered given the risk for delayed diagnosis and mortality. Most patients presented with abdominal pain and signs of hemorrhagic shock, although many had delayed onset of symptoms. Potential risk factors include prior abdominal surgeries, chronic pancreatitis, and difficult or prolonged procedures. Our review was limited by a low number of cases and inconsistent reporting of variables, which limited our statistical analysis.
- Open Access
Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Background/Objectives: Studies have shown that consistent reductions of 2 mm Hg in systolic blood pressure (SBP) for the general normotensive population can result in significant decreases in mortality from heart disease and stroke. The purpose of this meta-analysis was to determine the optimal dose and duration of treatment for magnesium and potassium supplementation, having previously discovered that both reduce SBP by −2.79 and −2.10 mm Hg, respectively. Methods: Placebo-controlled, randomized clinical trials examining the effects of magnesium and potassium supplementation on SBP were identified. Pairwise meta-analyses with subgroups for dosage and treatment duration were run. Results: Magnesium at dosages of ≤360 mg/day and durations greater than 3 months reduced SBP by −3.03 and −4.31 mm Hg, respectively. Potassium at dosages of ≤60 mmol/day and durations greater than 1 month reduced SBP by −2.34 and −2.80 mm Hg, respectively. Conclusions: Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations. Future studies are needed to validate these findings and provide tailored recommendations. These studies could investigate varying dosages over long-term follow-up to provide robust data on optimal dosages and treatment durations, as our findings were limited due to reliance on previously published trials.
Open AccessMagnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Background/Objectives: Studies have shown that consistent reductions of 2 mm Hg in systolic blood pressure (SBP) for the general normotensive population can result in significant decreases in mortality from heart disease and stroke. The purpose of this meta-analysis was to determine the optimal dose and duration of treatment for magnesium and potassium supplementation, having previously discovered that both reduce SBP by −2.79 and −2.10 mm Hg, respectively. Methods: Placebo-controlled, randomized clinical trials examining the effects of magnesium and potassium supplementation on SBP were identified. Pairwise meta-analyses with subgroups for dosage and treatment duration were run. Results: Magnesium at dosages of ≤360 mg/day and durations greater than 3 months reduced SBP by −3.03 and −4.31 mm Hg, respectively. Potassium at dosages of ≤60 mmol/day and durations greater than 1 month reduced SBP by −2.34 and −2.80 mm Hg, respectively. Conclusions: Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations. Future studies are needed to validate these findings and provide tailored recommendations. These studies could investigate varying dosages over long-term follow-up to provide robust data on optimal dosages and treatment durations, as our findings were limited due to reliance on previously published trials.
- Open Access
- 10 January 2024
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2024, 1-5
Malignant Epithelioid Mesothelioma of the Tunica Vaginalis Testis Presenting as Hydrocele in a Kidney Transplant Recipient
Mesotheliomas of the tunica vaginalis testis are rare malignant tumors that can present as a scrotal mass or hydrocele. These tumors are typically aggressive with high rates of recurrence and metastasis. Suspected risk factors for malignant mesothelioma include asbestos exposure, chronic inflammation, trauma, and persistent hydrocele. We report the case of a malignant epithelioid mesothelioma of the tunica vaginalis testis that presented as a finding at hydrocelectomy and was ultimately treated with radical inguinal orchiectomy. This patient was on chronic immunosuppression therapy with tacrolimus and mycophenolate mofetil secondary to a kidney transplant but had none of the common risk factors for mesothelioma formation. To our knowledge, this is the first case describing a possible connection between chronic immunosuppression and mesothelioma of the tunica vaginalis. However, future studies are needed to investigate this association and discern whether this could have played a role in our patient or if his mesothelioma formation was coincidental.
- 10 January 2024
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2024, 1-5
Open AccessMalignant Epithelioid Mesothelioma of the Tunica Vaginalis Testis Presenting as Hydrocele in a Kidney Transplant Recipient
Mesotheliomas of the tunica vaginalis testis are rare malignant tumors that can present as a scrotal mass or hydrocele. These tumors are typically aggressive with high rates of recurrence and metastasis. Suspected risk factors for malignant mesothelioma include asbestos exposure, chronic inflammation, trauma, and persistent hydrocele. We report the case of a malignant epithelioid mesothelioma of the tunica vaginalis testis that presented as a finding at hydrocelectomy and was ultimately treated with radical inguinal orchiectomy. This patient was on chronic immunosuppression therapy with tacrolimus and mycophenolate mofetil secondary to a kidney transplant but had none of the common risk factors for mesothelioma formation. To our knowledge, this is the first case describing a possible connection between chronic immunosuppression and mesothelioma of the tunica vaginalis. However, future studies are needed to investigate this association and discern whether this could have played a role in our patient or if his mesothelioma formation was coincidental.
- Open Access
Vitamins and Minerals for Blood Pressure Reduction in the General, Normotensive Population: A Systematic Review and Meta-Analysis of Six Supplements
Hypertension is the leading preventable risk factor for cardiovascular disease and all-cause mortality worldwide. However, studies have shown increased risk of mortality from heart disease and stroke even within the normal blood pressure (BP) range, starting at BPs above 110–115/70–75 mm Hg. Nutraceuticals, such as vitamins and minerals, have been studied extensively for their efficacy in lowering BP and may be of benefit to the general, normotensive population in achieving optimal BP. Our study investigated the effects of six nutraceuticals (Vitamins: C, D, E; Minerals: Calcium, Magnesium, Potassium) on both systolic blood pressure (SBP) and diastolic blood pressure (DBP) in this population. We performed a systematic review and pairwise meta-analysis for all six supplements versus placebo. Calcium and magnesium achieved significant reductions in both SBP and DBP of −1.37/−1.63 mm Hg and −2.79/−1.56 mm Hg, respectively. Vitamin E and potassium only yielded significant reductions in SBP with values of −1.76 mm Hg and −2.10 mm Hg, respectively. Vitamins C and D were not found to significantly lower either SBP or DBP. Future studies should determine optimal dosage and treatment length for these supplements in the general, normotensive population.
Open AccessVitamins and Minerals for Blood Pressure Reduction in the General, Normotensive Population: A Systematic Review and Meta-Analysis of Six Supplements
Hypertension is the leading preventable risk factor for cardiovascular disease and all-cause mortality worldwide. However, studies have shown increased risk of mortality from heart disease and stroke even within the normal blood pressure (BP) range, starting at BPs above 110–115/70–75 mm Hg. Nutraceuticals, such as vitamins and minerals, have been studied extensively for their efficacy in lowering BP and may be of benefit to the general, normotensive population in achieving optimal BP. Our study investigated the effects of six nutraceuticals (Vitamins: C, D, E; Minerals: Calcium, Magnesium, Potassium) on both systolic blood pressure (SBP) and diastolic blood pressure (DBP) in this population. We performed a systematic review and pairwise meta-analysis for all six supplements versus placebo. Calcium and magnesium achieved significant reductions in both SBP and DBP of −1.37/−1.63 mm Hg and −2.79/−1.56 mm Hg, respectively. Vitamin E and potassium only yielded significant reductions in SBP with values of −1.76 mm Hg and −2.10 mm Hg, respectively. Vitamins C and D were not found to significantly lower either SBP or DBP. Future studies should determine optimal dosage and treatment length for these supplements in the general, normotensive population.
- Open Access
- 3 March 2023
- Published by Hindawi Limited in Case Reports in Surgery
- Vol. 2023, 1-5
Rare Presentation of Small Bowel Obstruction Secondary to Intestinal Leiomyoma in a Patient with Crohn’s Disease
Small bowel obstructions (SBOs) are surgical emergencies that can occur with mechanical blockage of the intestinal lumen. These blockages are most commonly caused by adhesions or hernias, but can also result from intestinal neoplasms. This case report documents the rare occurrence of SBO due to a submucosal leiomyoma. This case was complicated by the patient’s longstanding history of Crohn’s disease, which has a considerable overlap in symptomatology with SBOs. This may have resulted in a delay in the patient’s diagnosis. Leiomyomas should always be considered as a potential, albeit rare, cause of SBO.
- 3 March 2023
- Published by Hindawi Limited in Case Reports in Surgery
- Vol. 2023, 1-5
Open AccessRare Presentation of Small Bowel Obstruction Secondary to Intestinal Leiomyoma in a Patient with Crohn’s Disease
Small bowel obstructions (SBOs) are surgical emergencies that can occur with mechanical blockage of the intestinal lumen. These blockages are most commonly caused by adhesions or hernias, but can also result from intestinal neoplasms. This case report documents the rare occurrence of SBO due to a submucosal leiomyoma. This case was complicated by the patient’s longstanding history of Crohn’s disease, which has a considerable overlap in symptomatology with SBOs. This may have resulted in a delay in the patient’s diagnosis. Leiomyomas should always be considered as a potential, albeit rare, cause of SBO.